Skip to content
  • Tuesday, 30 June 2026
  • 3:37 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Chiesi Acquires KalVista Pharmaceuticals for $1.9 Billion, Bolstering Rare Disease Portfolio with On-Demand HAE Treatment
Pharmaceutical R&D

Chiesi Acquires KalVista Pharmaceuticals for $1.9 Billion, Bolstering Rare Disease Portfolio with On-Demand HAE Treatment

Teuku Ryan May 3, 2026 0

In a landmark move that marks the largest acquisition in its 90-year history, Italian pharmaceutical giant Chiesi has agreed to…

Read More
The ‘Entry-Level’ Gatekeeper: Auditing Job Descriptions with Textstat for Enhanced Accessibility and Inclusivity.Salk Institute Researchers Identify BCL6 Protein as Key to Preventing Muscle Loss During GLP-1 Assisted Weight ManagementBreakthrough Combination Therapy Targets Cellular Differentiation Blocks to Provide New Treatment Pathway for Acute Myelogenous LeukemiaMillipede Lineages Unveiled: Groundbreaking Study Rewrites Ancient History of Earth’s First Terrestrial Colonizers
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveHigh-Dimensional Topological Structures Discovered in Entangled Photons Offer New Framework for Quantum Information StabilityWater-in-Diesel Emulsion Technology Offers Significant Emissions Reduction Potential Without Engine Modification
The Genetic Legacy of Paternal Aging: How Intra-Testicular Selection Drives Disease-Causing Mutations in SpermPens to pills: what oral GLP-1s change at the benchArc Protein Identified as Key Driver in the Spread of Toxic Tau Proteins in Alzheimer’s DiseaseTalawar Therapeutics and JATT II Acquisition Complete Business Combination to Advance Novel Immunology Therapeutics
YOU MAY HAVE MISSED
Stem Cell & Regenerative Medicine
The Genetic Legacy of Paternal Aging: How Intra-Testicular Selection Drives Disease-Causing Mutations in Sperm
Dwi Wanna Jun 30, 2026
Laboratory Automation & Robotics
Pens to pills: what oral GLP-1s change at the bench
Lana Keisha Jun 30, 2026
Neuroscience & Brain Research
Arc Protein Identified as Key Driver in the Spread of Toxic Tau Proteins in Alzheimer’s Disease
Rifan Muazin Jun 30, 2026
Pharmaceutical R&D
Talawar Therapeutics and JATT II Acquisition Complete Business Combination to Advance Novel Immunology Therapeutics
Teuku Ryan Jun 30, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ